EQ
Equillium, Inc.
There isn't enough reported data to score EQ yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
EQ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
EQ's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
EQ PE Valuation
EQ has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
EQ Forward outlook
There aren't enough analyst estimates for EQ to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
EQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.20 | +$0.42 |
| Q2 2026 | -$0.22 | +$0.34 |
| Q1 2026 | -$0.34 | +$0.05 |
| Q4 2025 | -$0.52 | -$0.29 |
| Q3 2025 | -$0.62 | -$0.49 |
| Q2 2025 | -$0.56 | -$0.32 |
| Q1 2025 | -$0.39 | -$0.04 |
| Q4 2024 | -$0.23 | +$0.15 |
EQ is still losing money, but far less than before: $0.20 per share over the past year, against $2.35 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over EQ on earnings quality, reporting a profit while its opponent remains loss making.
EQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $4.4M | -52% |
| Q3 2024 | $12.2M | +37% |
| Q2 2024 | $13.9M | +52% |
| Q1 2024 | $10.7M | +20% |
UNH has the stronger quarterly revenue trend. Revenue is down 52% for EQ versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -107% | -72 points |
| Q3 2024 | -5.6% | +35 points |
| Q2 2024 | -0.7% | +39 points |
| Q1 2024 | -26% | +20 points |
| Q4 2023 | -35% | N/A |
| Q3 2023 | -41% | N/A |
| Q2 2023 | -39% | N/A |
| Q1 2023 | -46% | N/A |
EQ's operating margin was −107% last quarter, down 72 points from the same quarter a year ago, near the bottom of its range since 2023.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
EQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.8M | +$4.6M |
| Q2 2026 | -$4.2M | -$1.2M |
| Q1 2026 | -$4.3M | +$3.9M |
| Q4 2025 | -$3.2M | +$126K |
| Q3 2025 | -$8.4M | -$774K |
| Q2 2025 | -$3M | -551% |
| Q1 2025 | -$8.2M | +$646K |
| Q4 2024 | -$3.3M | +$2.4M |
EQ has burned cash in almost every quarter: −$15M over the past year, against −$23M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over EQ on cash generation, producing positive trailing cash flow while its opponent burns cash.
EQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +118K shares |
| 1 year | +71% | +46.6M shares |
| 3 years | +221% | +77M shares |
| 5 years | +281% | +82.5M shares |
| Available history | +544% | +94.5M shares |
EQ has 112M diluted shares, up 71% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over EQ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
EQ Net Leverage
EQ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
EQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.6 | Neutral |
| Stochastic | 15.7 | Oversold |
EQ's weekly RSI is 37 (neutral) and its Stochastic is 16 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
EQ PE vs Healthcare Sector
EQ has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
EQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.39 | 5% below |
| 20 week MA | $1.98 | 33% below |
| 50 week MA | $1.94 | 32% below |
| 100 week MA | $1.38 | 4.3% below |
| 200 week MA | $1.19 | 11% above |
EQ has fallen below most of its moving averages, though it's still 11% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over EQ on trend strength, trading above more of its moving averages.
EQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.03 | $4.66 | +16% |
| 2021 | $4.66 | $4.49 | -3.6% |
| 2022 | $4.49 | $0.89 | -80% |
| 2023 | $0.89 | $0.72 | -19% |
| 2024 | $0.72 | $0.69 | -4.2% |
| 2025 | $0.69 | $1.50 | +117% |
| 2026 YTD | $1.50 | $1.32 | -12% |
EQ's yearly returns have swung widely, from +117% in 2025 to −80% in 2022. It's down 12% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over EQ on returns for 2026, with the stronger performance.